US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 49.680
  • +0.240+0.49%
Trading Mar 28 13:00 ET
3.05BMarket Cap11.74P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
624.06%434.43M
184.40%170.64M
4.68M
4.17M
254.95M
125.73%60M
60M
0
0
0
Operating revenue
624.06%434.43M
184.40%170.64M
--4.68M
--4.17M
--254.95M
125.73%60M
--60M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
18.18%181.59M
18.69%43.86M
20.36%46.13M
1.43%42.96M
35.04%48.64M
-2.72%153.65M
1.19%36.95M
18.65%38.33M
0.12%42.35M
-23.09%36.02M
Selling and administrative expenses
29.77%43.46M
11.20%8.95M
32.58%10.16M
2.92%9.44M
73.27%14.91M
5.52%33.49M
21.41%8.05M
11.03%7.66M
19.26%9.17M
-18.16%8.61M
-General and administrative expense
29.77%43.46M
11.20%8.95M
32.58%10.16M
2.92%9.44M
73.27%14.91M
5.52%33.49M
21.41%8.05M
11.03%7.66M
19.26%9.17M
-18.16%8.61M
Research and development costs
14.95%138.13M
20.78%34.9M
17.30%35.97M
1.02%33.52M
23.04%33.73M
-4.80%120.16M
-3.30%28.9M
20.71%30.66M
-4.13%33.18M
-24.51%27.42M
Operating profit
369.98%252.84M
450.05%126.78M
-8.16%-41.45M
8.41%-38.79M
672.75%206.31M
28.71%-93.65M
163.12%23.05M
-18.65%-38.33M
-2.20%-42.35M
-70.63%-36.02M
Net non-operating interest income expense
76.63%26.32M
61.55%6.85M
80.67%7.68M
89.22%7.4M
75.67%4.38M
266.95%14.9M
88.45%4.24M
267.50%4.25M
708.47%3.91M
1,382.74%2.49M
Non-operating interest income
76.63%26.32M
61.55%6.85M
80.67%7.68M
89.22%7.4M
75.67%4.38M
266.95%14.9M
88.45%4.24M
267.50%4.25M
708.47%3.91M
1,382.74%2.49M
Other net income (expense)
224.38%250K
-29.55%31K
554.84%141K
610.53%97K
90.26%-19K
-151.25%-201K
-38.03%44K
63.95%-31K
75.64%-19K
-1,600.00%-195K
Other non- operating income (expenses)
224.38%250K
-29.55%31K
554.84%141K
610.53%97K
90.26%-19K
-151.25%-201K
-38.03%44K
63.95%-31K
75.64%-19K
-1,600.00%-195K
Income before tax
453.88%279.41M
388.98%133.66M
1.39%-33.63M
18.64%-31.29M
724.66%210.67M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
Income tax
4.22M
1.99M
-420K
-676K
3.33M
0
0
0
0
0
Net income
448.54%275.19M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
Net income continuous Operations
448.54%275.19M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
Minority interest income
Net income attributable to the parent company
448.54%275.19M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
448.54%275.19M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
Basic earnings per share
421.58%4.47
368.89%2.11
6.90%-0.54
26.47%-0.5
608.96%3.41
46.54%-1.39
165.22%0.45
9.38%-0.58
19.05%-0.68
-55.81%-0.67
Diluted earnings per share
404.32%4.23
350.00%1.98
6.90%-0.54
26.47%-0.5
586.57%3.26
46.54%-1.39
163.77%0.44
9.38%-0.58
19.05%-0.68
-55.81%-0.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 624.06%434.43M184.40%170.64M4.68M4.17M254.95M125.73%60M60M000
Operating revenue 624.06%434.43M184.40%170.64M--4.68M--4.17M--254.95M125.73%60M--60M--0--0--0
Cost of revenue
Gross profit
Operating expense 18.18%181.59M18.69%43.86M20.36%46.13M1.43%42.96M35.04%48.64M-2.72%153.65M1.19%36.95M18.65%38.33M0.12%42.35M-23.09%36.02M
Selling and administrative expenses 29.77%43.46M11.20%8.95M32.58%10.16M2.92%9.44M73.27%14.91M5.52%33.49M21.41%8.05M11.03%7.66M19.26%9.17M-18.16%8.61M
-General and administrative expense 29.77%43.46M11.20%8.95M32.58%10.16M2.92%9.44M73.27%14.91M5.52%33.49M21.41%8.05M11.03%7.66M19.26%9.17M-18.16%8.61M
Research and development costs 14.95%138.13M20.78%34.9M17.30%35.97M1.02%33.52M23.04%33.73M-4.80%120.16M-3.30%28.9M20.71%30.66M-4.13%33.18M-24.51%27.42M
Operating profit 369.98%252.84M450.05%126.78M-8.16%-41.45M8.41%-38.79M672.75%206.31M28.71%-93.65M163.12%23.05M-18.65%-38.33M-2.20%-42.35M-70.63%-36.02M
Net non-operating interest income expense 76.63%26.32M61.55%6.85M80.67%7.68M89.22%7.4M75.67%4.38M266.95%14.9M88.45%4.24M267.50%4.25M708.47%3.91M1,382.74%2.49M
Non-operating interest income 76.63%26.32M61.55%6.85M80.67%7.68M89.22%7.4M75.67%4.38M266.95%14.9M88.45%4.24M267.50%4.25M708.47%3.91M1,382.74%2.49M
Other net income (expense) 224.38%250K-29.55%31K554.84%141K610.53%97K90.26%-19K-151.25%-201K-38.03%44K63.95%-31K75.64%-19K-1,600.00%-195K
Other non- operating income (expenses) 224.38%250K-29.55%31K554.84%141K610.53%97K90.26%-19K-151.25%-201K-38.03%44K63.95%-31K75.64%-19K-1,600.00%-195K
Income before tax 453.88%279.41M388.98%133.66M1.39%-33.63M18.64%-31.29M724.66%210.67M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M
Income tax 4.22M1.99M-420K-676K3.33M00000
Net income 448.54%275.19M381.70%131.67M2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M
Net income continuous Operations 448.54%275.19M381.70%131.67M2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M
Minority interest income
Net income attributable to the parent company 448.54%275.19M381.70%131.67M2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 448.54%275.19M381.70%131.67M2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M
Basic earnings per share 421.58%4.47368.89%2.116.90%-0.5426.47%-0.5608.96%3.4146.54%-1.39165.22%0.459.38%-0.5819.05%-0.68-55.81%-0.67
Diluted earnings per share 404.32%4.23350.00%1.986.90%-0.5426.47%-0.5586.57%3.2646.54%-1.39163.77%0.449.38%-0.5819.05%-0.68-55.81%-0.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Cisco
CSCO
60.650
NVIDIA
NVDA
109.480
ASML Holding
ASML
676.540
4
Adobe
ADBE
387.690
5
Taiwan Semiconductor
TSM
164.450
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.